J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ikejima, H.
Right arrow Articles by Yamamoto, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ikejima, H.
Right arrow Articles by Yamamoto, Y.
Agricola
Right arrow Articles by Ikejima, H.
Right arrow Articles by Yamamoto, Y.
J Med Microbiol 55 (2006), 947-952; DOI: 10.1099/jmm.0.46348-0
© 2006 Society for General Microbiology
ISSN 1473-5644

Chlamydia pneumoniae infection of microglial cells in vitro: a model of microbial infection for neurological disease

Hideaki Ikejima1,2, Herman Friedman1 and Yoshimasa Yamamoto1,3

1 Department of Medical Microbiology and Immunology, University of South Florida College of Medicine, Tampa, FL 33612, USA

2 Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan

3 Laboratory of Molecular Microbiology, Department of Basic Laboratory Sciences, Osaka University Graduate School of Medicine, 1-7 Yamadaoka, Suita, Osaka 565-0871, Japan

Correspondence
Yoshimasa Yamamoto
yyamamot{at}sahs.med.osaka-u.ac.jp

Received 28 September 2005
Accepted 9 February 2006

Chlamydia pneumoniae is the aetiological cause of a wide variety of chronic inflammatory diseases and may be associated with neurological disease. Microbiological and immunological aspects of the interaction between C. pneumoniae and the central nervous system (CNS) are not well understood because of the lack of a suitable infection model for neuronal studies. In the present study, an in vitro C. pneumoniae infection model was developed in the established microglial cell line EOC 20. Infection of the cells resulted in obvious induction of proinflammatory cytokines. The infection also selectively induced matrix metalloproteinase-9 (MMP-9) but not MMP-2. Moreover, beta interferon, which is known to modulate CNS disease, inhibited induction of MMP-9 following C. pneumoniae infection. These results support the view that C. pneumoniae infection may be associated with marked alteration of the ability of microglial cells to enhance cytokine production as well as induction of an MMP.

Abbreviations: CNS, central nervous system; IFN-ß, beta interferon; IFU, inclusion-forming units; IL-10, interleukin-10; IL-12, interleukin-12; MMP-9, matrix metalloproteinase-9; MS, multiple sclerosis; TIMP-1, tissue inhibitor of metalloprotease 1; TNF-{alpha}, tumour necrosis factor {alpha}.




This article has been cited by other articles:


Home page
 Mult SclerHome page
J. Parratt, R. Tavendale, J. O'Riordan, D. Parratt, and R. Swingler
Chlamydia pneumoniae-specific serum immune complexes in patients with multiple sclerosis
Multiple Sclerosis, April 1, 2008; 14(3): 292 - 299.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2006 Society for General Microbiology.